Biomere

Biomere is a preclinical contract research organization (CRO) located in Worcester, MA, in the greater Boston area. The company specializes in non-GLP PK/PD and early toxicology studies across small and large animal models, including non-human primates.

Core Capabilities

• PK/PD Studies: Comprehensive pharmacokinetics and pharmacodynamics evaluation to support go/no-go decision-making in preclinical drug development
• Early Toxicology: Non-GLP toxicology assessments designed to evaluate dosing, distribution, metabolism, efficacy, and off-target effects
• Animal Models: Extensive expertise in rodent and large animal models; disease-specific models including ocular, CNS, metabolic, and oncology applications
• Endpoint Analysis: Fully equipped laboratories with multidisciplinary scientific support
• Gene Therapy PK/PD: Specialized services for gene therapy candidates
• Colony Management & Surgical Services: In-house vivarium resources and surgical capabilities

Regulatory & Accreditation

Biomere is AAALAC accredited, OLAW Assured, DEA Licensed, and USDA Registered. The organization is part of JOINN Laboratories (acquired in 2019), which extends access to GLP-compliant preclinical services through JOINN's facilities in China (Suzhou, Beijing, Wuzhou, Chongqing, Guangzhou) and a secondary U.S. location in Richmond, CA.

Approach

The company emphasizes a personal, client-focused approach with dedicated project resourcing, model availability, and expedited study start times. Scientific teams work closely with clients to design budget-optimized study protocols that support informed decision-making during the transition from lead optimization to IND-enabling studies.